MedPath

The effect of exercise training and spirulina supplementation on type 2 diabetes

Early Phase 1
Conditions
Type 2 diabetes.
Type 2 diabetes mellitus
Registration Number
IRCT20171008036653N2
Lead Sponsor
The University of Qom
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
60
Inclusion Criteria

No clinical signs of cardiovascular disease
T2D detection < 10 years ago Ages 40 to 50years old
No dependency to insulin
The use of commonly used diabetes medications, such as metformin and glenalbelamine

Exclusion Criteria

Cardiovascular disease
Coronary artery disease
Atrial fibrillation
High blood pressure
Congenital heart disease Retinopathy Neuropathy
Body mass index 25-30
Ischemia in echocardiography
Disability that causes difficulty in practice

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Serum Resistin in women with type 2 diabetes. Timepoint: One day before the session begins and 48 hours after the end of the exercise. Method of measurement: The serum level of resistin will be measured by ELISA and using a commercial kit under the manufacturer's protocols (ZellBio GmbH, Germany).;Serum CRP in women with type 2 diabetes. Timepoint: One day before the session begins and 48 hours after the end of the exercise. Method of measurement: The serum level of CRP will be measured by ELISA and using a commercial kit under the manufacturer's protocols .
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath